MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Immunomedics Company Profile (NASDAQ:IMMU)

Consensus Ratings for Immunomedics (NASDAQ:IMMU) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $4.63 (135.97% upside)

Analysts' Ratings History for Immunomedics (NASDAQ:IMMU)
Show:
DateFirmActionRatingPrice TargetActions
7/29/2015OppenheimerReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Jefferies GroupDowngradeBuy -> Hold$6.00 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/16/2015Wells Fargo & Co.Initiated CoverageOutperform -> Fair ValueView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Wells Fargo & Co.Initiated CoverageOutperform -> Outperform$7.00 -> $7.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2014Panmure GordonReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2014Jefferies GroupInitiated CoverageBuy$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2014R. F. LaffertyDowngradeBuy -> Neutral$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2014Chardan CapitalInitiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2013OppenheimerBoost Price TargetOutperform$6.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2013R. F. LaffertyInitiated CoverageBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/28/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha